Starting out on Wall Street, Palo Alto's BridgeBio Pharma, which markets drugs for a rare heart condition, saw its shares ...
The firm's founder is still working after 55 years. He has ideas about downtown Denver revitalization — including demolition.
Don't let Google's war on ad blockers ruin your streaming experience. From alternative browsers to Manifest V3 options, there ...
AI notetakers can quickly summarize meetings and create to-do lists, but they raise privacy concerns. Everything said in a ...
Angry protestors held a stand-off with police and attempted to gain entry to the home of an alleged sex attacker shouting 'get them out'.
Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results